NDTVHealth
PopVax Launches Facility for Personalised Cancer Vaccines
Indian startup PopVax has launched a new facility to develop personalised cancer vaccines using messenger ribonucleic acid technology. The company says it will support tailored vaccine development, but details about clinical trials, availability, and treatment outcomes were not provided.
This card is an AI-assisted summary of reporting published by NDTV. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.